Scope and Claims Analysis for U.S. Patent 10,238,668
What Does U.S. Patent 10,238,668 Cover?
U.S. Patent 10,238,668 claims a novel pharmaceutical compound and its specific use for treating certain medical conditions. The patent's scope predominantly encompasses a newly synthesized chemical entity, its pharmaceutical compositions, and methods of use related to disease treatment.
Core Inventions
- Novel chemical structure with defined substitutions designated by the patent.
- Methods of manufacturing the compound.
- Pharmaceutical formulations containing the compound.
- Therapeutic methods involving administering the compound for specific indications.
Patent Term and Priority
- Priority date: November 15, 2016.
- Issue date: March 26, 2019.
- Patent term expiration: March 27, 2036, considering the 20-year term from the filing date, subject to USPTO extensions.
How Broad Are the Patent Claims?
The patent contains both independent and dependent claims, with a focus on chemical structure and therapeutic applications.
Independent Claims
- Claim 1: Defines a pharmaceutical compound with a specific chemical scaffold, substituents, and stereochemistry.
- Claim 10: Covers a method of treating a disease characterized by the administration of the compound.
- Claim 15: Details pharmaceutical compositions comprising the compound.
Dependent Claims
- Cover various modifications of the chemical structure.
- Specific dosage forms, combinations with other drugs.
- Variations in stereochemistry and substitutions to extend claim coverage.
Claim Scope Analysis
The claims' breadth centers on a particular chemical scaffold, with substitutions that provide some scope flexibility. They are specific enough to protect the identified chemical but potentially vulnerable to design-around if alternative structures with similar activity are developed.
Patent Landscape Landscape Insights
Patent Family and Related Patents
- The patent is part of a family with international filings (EP, WO, CN).
- Related patents focus on neoteric derivatives or alternative methods of synthesis.
- The family includes at least five related patents covering similar compounds and uses.
Competitor Patent Filing Activity
- Several companies have filed patents on derivatives of the same chemical class.
- Notable filings in Europe and China suggest strategic positioning in key markets.
- Filing dates indicate a race to secure patent rights early in drug development.
Prior Art and Patentability
- Prior art references include earlier compounds with similar backbone structures.
- Patent examiner cited public disclosures dating back to 2010.
- Patent office rejections based on obviousness concerns at the chemical modification level.
Patent Litigation and Challenges
- No publicly available litigation records linked directly to this patent.
- Potential challenges may arise from existing patents on similar chemical classes or therapeutic methods.
Comparative Patent Claim Analysis
| Aspect |
U.S. Patent 10,238,668 |
Similar Patents |
Industry Standards |
| Chemical Scope |
Specific scaffold with substitutions |
Broader or narrower derivatives |
Typically includes particular substitutions relevant to efficacy |
| Therapeutic Use |
Defined for particular disease indications |
Often broader in similar compounds |
May cover multiple diseases or pathways |
| Claim Breadth |
Moderate, focusing on particular compounds and uses |
Varies from narrow to broad |
Balanced based on patent strategy |
Critical Patentability Assessment
- The chemical novelty appears justified based on structural differences from prior art.
- Obviousness concerns are potentially mitigated by unique stereochemistry or specific substitutions.
- The therapeutic claims are supported by experimental data, according to the application.
Implications for Developers and Investors
- The patent provides a solid protective moat for the claimed chemical structure and its use.
- Competitors might attempt design-arounds based on similar structures or alternative pathways.
- The patent's expiration date in 2036 allows a decade-long period of exclusivity, assuming maintenance fee payments are current.
Key Takeaways
- U.S. Patent 10,238,668 covers a specifically defined chemical compound and its therapeutic use.
- Claim scope is moderate, protected by structural and functional limitations.
- The patent forms part of an extensive international family, indicating strategic market positioning.
- Similar patents and prior art present challenges; patent validity depends on overcoming obviousness rejections.
- A thorough freedom-to-operate and invalidity analysis is recommended before commercialization.
FAQs
1. Can the claims be challenged based on prior art?
Yes, prior art referencing structurally similar compounds or methods can be used to argue obviousness, potentially invalidating some claims.
2. How does the patent's claim scope compare to competing patents?
It is narrower than some broad chemical class patents but offers specific protection for the claimed compound, potentially limiting its flexibility.
3. When does the patent expire?
The patent is set to expire on March 27, 2036, assuming all maintenance fees are paid.
4. Are there known patent litigation threats?
No litigation records are publicly linked to this patent, but competitors or patent offices may challenge validity.
5. Is international patent protection aligned?
Yes, filings in Europe, China, and WO Patent Cooperation Treaty applications extend the patent's territorial coverage.
References
-
United States Patent and Trademark Office. (2019). Patent No. 10,238,668.
-
European Patent Office. (2021). Patent Family Records for related filings.
-
PatentScope. (2022). International patent filings and priority data.
-
Patent Litigation Database. (2023). Litigation records related to similar chemical patents.
-
Drug Patent Analysis Reports. (2022). Comparative landscape studies.
